Delisting risk
MDCX · NASDAQ · Biotechnology

Medicus Pharma (MDCX)

Develops clinical-stage therapies for skin cancer, urology, oncology, and women’s health.

$0.2600
Pre-market+0.00 (+0.89%)
At close$0.2577(+2.59%)

Breakdown13F · 13D/G · Form 4

Institutions20 holders · as of Mar 31, 20263.67%2.32M shares
Insiders11 holders · as of Sep 8, 202510.40%6.57M shares
Strategic holders1 holder · as of May 21, 202510.40%6.57M shares
Otherremainder75.53%47.72M shares

63.18M company shares as of Sep 3, 2026 · institutions as of Mar 31, 2026 · holders as of their latest filing

Two share counts disagree (63.18M in the company's Sep 3, 2026 report, 22.04M elsewhere); stakes use the report.

Top shareholders13F · 13D/G · Form 4

HolderStakeSharesEvidence
Velocity Fund Partners, LPStrategic10 percent owner
10.40%6.57MForm 4filed May 21, 2025
Kenneth R. MelaniInsider10 percent owner
5.26%3.32MForm 4filed Dec 31, 2024
Ajay Raju1Insider10 percent owner
3.17%2.00MForm 4filed Dec 31, 2024
Interchange Capital Partners, LLCInstitution
2.63%1.66M13Fas of Mar 31, 2026
Raza Bokhari2Insiderdirector, officer: Chief Executive Officer
1.26%793,173Form 4filed Feb 10, 2025
James P. QuinlanInsiderofficer: Chief Financial Officer
0.43%274,147Form 4filed Aug 14, 2025
Private Advisor Group, LLCInstitution
0.38%240,05513Fas of Mar 31, 2026
Edward J. BrennanInsiderofficer: Chief Scientific Officer
0.14%86,500Form 4filed Dec 31, 2024
Virtu Financial LLCInstitution
0.12%74,04513Fas of Mar 31, 2026
BRYN Mawr Trust CoInstitution
0.08%51,24413Fas of Mar 31, 2026
May Hill Capital, LLCInstitution
0.08%50,62213Fas of Mar 31, 2026
Commonwealth Equity Services, LLCInstitution
0.08%48,14313Fas of Mar 31, 2026
UBS Group AGInstitution
0.06%40,44113Fas of Mar 31, 2026
BlackRock, Inc.Institution
0.06%37,29413Fas of Mar 31, 2026
Patrick J. MahaffyInsiderdirector
0.06%35,435Form 4filed Sep 8, 2025
Frank W. LavelleInsiderdirector
0.04%25,622Form 4filed Dec 31, 2024
Carolyn F. BonnerInsiderofficer: President
0.03%18,905Form 4filed Dec 31, 2024
Citadel Advisors LLCInstitution
0.03%17,82413Fas of Mar 31, 2026
Two Sigma Securities, LLCInstitution
0.02%15,61713Fas of Mar 31, 2026
LPL Financial LLCInstitution
0.02%15,61213Fas of Mar 31, 2026
Marathon Capital ManagementInstitution
0.02%15,50013Fas of Mar 31, 2026
Stonex Group Inc.Institution
0.02%15,16913Fas of Mar 31, 2026
Robert J. CiaruffoliInsiderdirector
0.02%12,500Form 4filed Dec 31, 2024
Smithfield Trust CoInstitution
0.02%11,48013Fas of Mar 31, 2026
Brave Asset Management IncInstitution
0.02%10,00013Fas of Mar 31, 2026
  1. Reported at 3.70% on May 5, 2026, under the 5% line, so no further filing is required.
  2. Reported at 4.80% on Jan 5, 2026, under the 5% line, so no further filing is required.

13F — a manager's quarterly holdings · Form 4 — an insider's transaction report

Institutions13F, as of Mar 31, 2026

20 holders · 2.32M shares · 7 new positions · 13 increased · 3 reduced · 8 closed

HolderShares% outstandingChg q/qFiled
Interchange Capital Partners, LLC1.66M2.63%+75.0KApr 24, 2026
Private Advisor Group, LLC240.1K0.38%+64.6KApr 27, 2026
Virtu Financial LLC74.0K0.12%+74.0KnewMay 14, 2026
BRYN Mawr Trust Co51.2K0.08%0Apr 30, 2026
May Hill Capital, LLC50.6K0.08%+15.0KMay 6, 2026
Commonwealth Equity Services, LLC48.1K0.08%+19.7KApr 27, 2026
UBS Group AG40.4K0.06%+27.2KMay 5, 2026
BlackRock, Inc.37.3K0.06%+3.0KMay 13, 2026

Ownership statements13D/G · 5% or more, as filed

Holder% of classSharesFormFiled
Melani Kenneth R.18.20%3.25M13GAug 12, 2025
Ajay Raju16.90%2.00M13GJan 13, 2025

Insider tradesForm 4

Latest trades

No open-market trades in the last 12 months.

CongressHouse and Senate disclosures

Not reported.